A key amino acid substitution specific for allotypic Gm b markers, b0, b3, b5, were determined through sequence analyses of the pFc' fragments of IgG1 (Su) 2361] that two residues, the serine and isoleucine specific for IgG3 subclass at position 422, cause the structural change responsible for b markers. The two residues are close to each other in the CH3 domain. The allocations of the epitopes are estimated to be on two bends (residue no. [382][383][384][385][386][387][388][389][390][391][392][411][412][413][414][415][416][417][418][419][420][421][422][423][424] between the beta-strands, whose amino acid residues are present in wide contact area [Novotny et al.
INTRODUCTION
Gm allotypic markers of human immunoglobulins are identified as the antigenic differences by the hemagglutination inhibition test with specific antibodies (Grubb, 1970) . This highly polymorphic system has been utilized for population studies (Matsumoto, 1989) , forensic applications (Lange et al., 1988) , or medical studies (Matsumoto, 1988) . The detectable antigenic determinants of IgG molecule are distinguished as the specific structures derived from one or a few amino acid substitutions in the constant portion (Turner, 1970) . Although the substitutions of several Gm markers have been established through sequence analysis of IgG proteins, most of them are still unsettled (Schanfield et al., 1986) . We determined a key substitution of Gmb markers, b0, b3, b5, through sequence analyses of the pFc' fragment of four myeloma proteins (Su, Ba, Bu, and Kam) and discussed the distribution of the epitopes on IgG molecule in this paper.
MATERIALS AND METHODS
Preparation for myeloma proteins. Each IgG protein (Su:[Gm(a)], Ba :[Gin(g)], Bu[Gm(blb3)], Kam:[Gm(b3st)]) was isolated from the serum of multiple myeloma patients by ion-exchanger (Whatman DE-52) and affinity (Pharmacia Protein ASepharose CL-4B) chromatography . Gm typing was carried out by means of the classical hemagglutination inhibition test (Matsumoto and Takatsuki, 1968) .
Preparation of pFc' J?agments. Purified IgG protein (20 mg/ml) disolved in 0.1 ~ acetate buffer (pH 4.5) was incubated with pepsin (Millipore)at E/S ratio 1:100 (w/w) for 24 hr (IgG1) or 1 hr (IgG3) at 37~
The reaction was stopped by addition of 0.1 g Tris(hydroxymethyl)aminoethane (Tris) per 1 ml of the mixture. The digest was applied to Sephacryl S-200 (Pharmacia, column size=l.9 x 90 cm) equilibrated with 0.2 M ammonium bicarbonate (pH 8.2) (Natvig and Turner, 1971) .
Red~ction and carboxymethylation. The separated pFc' fragment was reduced with 2-mercaptoethanol in 0.5 M Tris-HCl buffer (pH 8.5) containing 8 M urea and 0.2 ~ ethylenediaminetetraacetic acid for 4 hr at 37~ and then was carboxymethylated with monoiodoacetic acid (Merk) for 20rain (Gurd, 1967) . The reaction mixture was desalted on Sephadex G-25 (Pharmacia, PD-10 column) in 0.2 N formic acid.
Lysylendopeptidase digestion and separation q[ the lysyl-peptides. The carboxymethylated pFc' fragment (5 mg/ml) dissolved in 10 mM Tris was digested with lysylendopeptidase (Wako) at E/S ratio 1:100 (w/w) for 6 hr at 30~
The mixture was immediately lyophilized and then dissolved in 0.1 ~ trifluoroacetic acid (TFA). High-performznce liquid chromatography (HPLC) of the digest was performed on Shimadzu LC-6A system with Cosmosil 5C18 (Nakarai, column size=4.6x 150 mm, 5ym). Peptides in the column effluent were detected at 210 pm. For further analysis, a lysyl-peptide was digested by Stap.#ylococcus aureus V8 protease (Miles) (E/S ratio--I/50) for 24 hr at 37~ in 0.05 M ammonium bicarbonate. ]-he VS-peptides were separated by HPLC under the same conditions.
Amino acid analysis and sequence analysis. Samples were hydrolyzed with 6 N HC1 in an evacuated and sealed Pyrex tube at 110~ for 24 hr. Amino acids of a dried hydrolysate were modified to phenylthiocarbamate (PTC) derivatives with phenylisothiocyanate (PITC) in coupling buffer (Bidlingmeyer et al., 1984) . The PTC amino acids were analyzed by HPLC using LiChrosorb RP-8 (Merk, 4 x250 mm, 5~m) column (Ito et al., 1987) .
Sequence analysis. Manual Edman degradation was carried out according to the procedures previously described (Ito et al., 1990) . The peptide was allowed to react with PITC in 0.4 M dimethylallylamine/propanol-water (6:4, v/v, pH 9.5) under a nitrogen atmosphere at 50~ for 30 min. After extracting with benzene, the reaction mixture was dried in vacuo. Cleavage reaction was subsequently performed with trifluoroacetic acid at 50~ for 10 min. The resulting thiazolinone was extracted with ethyl acetate, and then was converted to a phenylthiohydantoin (PTH) amino acid with 1 N HC1. PTH-amino acids were identified by HPLC with a Cosmosil 5C18 (Nakarai, 4.6 x 150, 5 f~m) column.
Nomenclature.
Lysyl peptides are given the prefix L and numbered consecutively in their order of the sequence. V8 peptides generated from the further digestion of peptide L6 are named VI', V2', and V3-4'.
RESULTS
Myeloma proteins were purified from the sera of multiple myeloma patients using DE-52 and Protein A-Sepharose CL-4B chromatography. IgG1 (Su) and IgG3 (Kam) myeloma proteins were found in the bound fractions and IgG3 Ba and Bu were in the non-bound fractions eluted from the affinity column. The purity was checked by Gm typing on serially eluates and by disc electrophoresis. Pt~-rifled IgG protein Su, Ba, Bu, and K am had Glm(a), G3m(g), G3m(bl,b3), and G3m(b3,t), respectively. The desalted and lyophilized samples were digested by pepsin, and then the resulting pFc' fragments were separated by gel filtration in a volatile buffer. The N-terminal sequence analysis of carboxymethylated pFc' (Su) fragment was carried out until 12th steps by manual Edman degradation. The N-terminal sequences of the other pFc's were determined until 8th amino acid. Carboxymethylated pFc' fragment was digested with lysylendopeptidase. The digest was applied to a reverse-phase HPLC column. The lysyl peptides of Su and Kam were separated into 8 peaks on the chromatograms, while those of Ba and Bu were separated into 7 peaks, as shown in Fig. 1 . The N-terminal peptide L1 and the 3rd peptide L3 were not recovered in all the cases. For further sequence analysis, peptide L6 derived from pFc' Su and Kam were digested with V8 protease, and the digests were found to be separated into 3 peaks (VI', V2', and V3-4') on a HPLC column according to the described conditions. These V8 peptides were analyzed by manual Edman degradation. On the other hand, three peptides (VI', V2', and V3-4'-LT) were also obtained from peptide L6-7 of pFc' Ba and Bu by the same treatment. The sequences of peptides VI' were completely determined, and those of peptide V3-4'-L7 were determined until l lth steps. The N-terminal 9 amino acids of peptides L9 of all samples were determined. The complete sequence of the remaining peptides was not determined, because all of these were readily identifiable from the homology with those of the constant region of IgG1 (Eu) on the basis of amino acid composition (Edelman et al., 1969) . Amino acid analyses of the peptides are in good agreement with their deduced primary struc- Chromatography profiles of the lysyl peptides derived from carboxymethylated pFc' fragments carrying various Gm allotypes. Protein Su, Ba, Bu, and Kam had Glm(a), G3m(g), G3m(blb3), and G3m(b3st), respectively. HPLC was performed on a reversed-phase column, Cosmosil 5C18. The conditions are described in the MATERIALS AND METHODS. Wang (1980) and Pink (1970) . ture. Partial sequence analyses of the tryptic peptides of carboxymethylated pFc' Kam had been carried out in our previous study . The C-terminal BrCN peptides of Ba and Bu had been analyzed in one of our studies (Ito et al., 1990) . The above results of the sequence analyses are summarized in Fig. 2 and sequence differences between the pFc' fragments of proteins (Su, Ba, Bu, and Kam) and the other IgGs are presented in table. DISCUSSION Protein Ba of which we analyzed for the sequence has G3m(g5) markers on the CH3 domain. Protein Bu has G3m(b0)(b3)(b5), which are represented by 'b' marker, while Kam has G3m(s)(t) and 'b' marker on the CH3 domain (Natvig and Turner, 1971; Schanfield et al., 1986; Matsumoto et al., 1986) . Both Bu and Kam molecules have 'b' marker, whereas Ba molecule has no marker. The antigenic determinants of these Gm allotypic markers, which are serologically detected by the specific antibodies, may be due to changes in the tertiary structures derived from one or a few amino acid substitutions in the constant region of immunoglobulin G (Turner, 1970) . We attempted to determine the amino acid residue responsible for the 'b' marker by the sequence analyses of pFc' fragments of the myeloma proteins. Protein Bu and Kam have the same residues at positions 339 and 384, while ]3a has the different residues to those, as shown in the comparison table. The substitution of threonine for alanine at position 339 may not be responsible for the serological difference, because both residues appear in all subclasses. Accordingly, the presence of serine residue at position 384 must be the amino acid responsible for 'b' marker. IgG3 protein having g5 marker or IgG belonging to IgG1,2,4 subclasses has asparagine in the identical position. The result indicates that IgG carrying 'b' marker gained the three antigenicities (b0, b3, and b5) by the substitution. It is probable that some structural changes around the residue are caused by one amino acid exchange. We subsequently considered the allocation of epitopes of 'b' marker on the tertiary structure of IgG. The epitopes of the following Gm markers are distinguished from the others on the basis of one exchange; Glm(f) to Glm(z): lysine to arginine (Edelman et al., 1969; Polmar et al., 1964; Hogg, 1969, 1970) , Glm(x): glycine to alanine (Cook and Steinberg, 1979; Ito et al., 1989) , Glm(gl): glutamic acid to glutamine , G3m(t): methionine to valine (Matsumoto et al., 1983) . The single amino acid residue corresponds to specific serological specificity in these cases. On the other hand, the amino acid (serine at position 384) corresponds to the three antigenic specificities in the case of 'b' marker. Thus other residues must be involved in the markers. Isoleucine at position 422 specific for IgG3 subclass is adjacent to the serine in the tertiary structure (Deisenhofer et al., 1976) . It is supposed that the coupled residues, serine and isoleucine, ptay an important role in the drastic change.
Various methods have been employed for estimating antigenic determinants on a protein on the basis of amino acid sequence data or crystallographic data. They are based on various guidances, such as segmental mobility (Westhof et aL, 1984) , hydrophilicity (Hopp, 1986) , large probe accessibility (Novotny et al., 1987) , high local mobility, convex surface shape, or negative electrostatic potential (Geysen etk al., 1987) . In brief, the epitopes of protein are determined by residues of the sites with a high accessibility of water molecule. The contact surface profile of IgG1-CH3 domain, which constitutes five peaks (I-V) having wide contact area, are shown in the review described by Novotny (1987) . All residues in the peak I-V are present on the bend between two beta-strands in CH3 domain. It is clear that such hydrophilic peaks have antigenicity. Because they include residues specific for some Gm markers, Glm(a) in peak I (position 356 and 358) (Frangione et al., 1966; Gottlieb et aL, 1968; Turner et al., 1969; Wang et al., 1969) , Glm(x) in V (431) (Cook and Steinberg, 1979 ), G3m(s) in V (435) (Matsumoto et al., 1983) , and G3m(g5) in V (435 and 436) (Ito et al., 1990) . Peak II and IV have serine at position 384 and isoleucine at position 422, respectively, and yet region II is close to IV on the molecule. Probably, these regions are the epitopes of Gm 'b' marker. The crystallographic study of antiboy-lysozyme complex revealed that an epitope is determined by many amino acid residues. Thus, 16 residues of lysozyme interact with 17 residues of the antibody by van der Waals forces and hydrogen bonds (Amit et al., 1986) . The antibodies against Gm 'b' marker likely recognize wide areas on IgG3 molecule. The allocations of the epitopes are estimated to be on two bends of residue no. 382-392 and 411-424. We cannot determine the position of each b marker, b0, b3 or b5, without additional experimental result. The epitope of only b0 marker is, however, estimated to consist of some residues between serine at position 384 and proline at position 445. Because the proline is absent in IgG4 protein which don't have non-b0 marker. This nonmarker is found on immunoglobulins belonging to the other subclasses (Shanfield et aL, 1986) .
Approaches to the epitope specificity of Gm markers will promote our understanding of the antigenic structure of immunoglobulins.
